The applicability of a stochastic model was explored to assess the impact of a new independent agency for animal health in England in terms of the cost of animal disease outbreaks. The new agency was proposed to take responsibility for animal disease management in England. The stochastic model estimates the likelihood that the proposed new agency would face animal disease outbreaks of major and minor magnitude; and how many outbreaks of each magnitude, within its first 30 years of operation. Large variability in the potential total cost of the new agency was attributable to the possibility of an outbreak of an unknown major disease, although Bluetongue, Foot and Mouth Disease, and Avian Influenza were also influential. The results show that if the new agency reduces disease costs by even 0.5%, this could benefit society by an estimated £21 million per year. The stochastic approach offers a method for dealing with uncertainties in any continuing deliberations regarding the proposed new agency, resulting in a potential annual gain of £73 million ranging to an annual loss of £144 million.
INTRODUCTION
Outbreaks of animal diseases have enormous economic, social, and environmental consequences to the UK national economy (Anderson 2002 (Anderson , 2008 . Mitigating these requires a comprehensive and informed risk management scheme. Currently in the United Kingdom, the responsibility for animal disease management lies with the Department for Environment, Food and Rural Affairs (Defra) . This responsibility was proposed to transfer to a new independent agency for animal health in England by 2012, although Defra ministers would retain overall responsibility for animal disease policy (Defra 2009a) . The proposed new agency (herein, "the new agency") was part of the Government's drive to achieve efficiency in animal disease management in England. To assess the investment potential of the new agency, Defra (2009b) relied on expert opinion about disease risks based on the return periods (RP) of Avian Influenza, Bluetongue, Newcastle Disease, Classical Swine Fever, Foot and Mouth Disease, African Swine Fever, and Swine Vesicular Disease. The RP is the mean length of time between outbreaks that have equalled or exceeded a certain magnitude. The reciprocal of the RP is a probability estimate of the event occurring in any given year (Ozger and Sen 2008) .
Return periods are widely used to reflect the magnitude of flood events, but a limitation of using the RP of diseases to assess the risk of future animal disease outbreaks is that the RP does not account for variations in the distribution of what are often rare outbreaks involving highly complex chains of precursor events (Gosling et al. 2011) . For example, as the new agency has been proposed to exist for 30 years (Defra 2009b ), a disease with an RP of 60 years may or may not occur during the lifespan of the new agency. This can affect the rationale for the new agency. Here, we use a stochastic model to build on the RP of the diseases (Defra 2009b) in order to assess the impact of the new agency. The stochastic model was developed to estimate the likelihood that the new agency would face disease outbreaks of both major and minor magnitude; and more importantly, how many outbreaks of each magnitude, within its first 30 years of operation. It uses the estimated costs of disease outbreaks and the running costs of the new agency to present the possible benefits of the new agency under four hypothetical scenarios.
METHODS
A stochastic model was developed to estimate the number of animal disease outbreaks that may occur within the 30-year lifespan of the new agency. Adopting a stochastic approach allowed the incorporation of variability (Ranjan and Lubowski 2005) , and provided additional information to the expected number of outbreaks (e.g., 5th and 95th percentiles).
To make decisions covering the lifespan (30 years) of the new agency, the number of minor and major outbreaks of animal disease were estimated. The distinction between major and minor outbreaks is a simplistic representation of disease outbreaks that encompasses the average costs for minor disease outbreaks controlled at low cost, and much rarer years of one (or even more) major high cost disease outbreak(s). These range from small (one animal or premises affected, with minimal trade disruption) to nationwide (thousands of affected premises, very high eradication costs, and long disruption to businesses) (Defra 2009b ). This enabled an estimation of the total cost of outbreaks to which set-up and running costs of the new agency could be added. Data available from Defra (2009b) provided information on the likely frequency (i.e., an outbreak once every "how many" years) of an exotic disease outbreak for different diseases (Table 1) . Using these data, the analysis focused on nine diseases, that is, Avian Influenza (AI), Bluetongue (BT), Newcastle Disease (ND), Classical Swine Fever (CSF), Foot and Mouth Disease (FMD), African Swine Fever (ASF), and Swine Vesicular Disease (SVD). It is important to emphasize that the probabilities and costs provided by Defra reflect expert opinion about disease risks based on the information available. The data used by the Government's expert elicitation panel dates back to year 1866 (Defra 2009b) . The figures are not intended to be forecasts nor predictions of what will happen; rather to illustrate the possible scale of outbreak costs in a year to show what might be achieved by reducing those costs.
The stochastic model was developed using the @Risk TM (v5.5, Palisade Corporation) add-on to Microsoft Excel (Charles and Ashbolt 2004). To estimate the number of outbreaks of disease i (i = 1, . . . , 9) within a 30-year period (O i ) a Poisson distribution was used (Vose 2008) , which assumes that each outbreak is independent of each other (IRMA 2003; Williams et al. 2009 ). This is given as
where y i is the estimated number of years between outbreaks of disease i, which is given from Table 1 . The cost of the disease outbreak is dependent on whether the outbreak is major or minor. The probability of a minor outbreak of disease i (P i,Minor ) and the probability of a major outbreak of disease i (P i,Major ) were also taken from Defra (2009b) and are detailed in Table 1 . Using the probability P i,Minor , the number of minor outbreaks (O i,Minor ) was determined by a Binomial distribution:
and therefore, the number of major outbreaks (O i,Major ) was given by subtracting the number of minor outbreaks from the total number of outbreaks (i.e.,
The cost C i of outbreaks of animal disease i in the 30-year period was therefore calculated as:
The y i and c i,major of "unknown major disease" were determined by Defra (2009b) based on their historical data of outbreaks that are, for example, similar in scale to the BSE outbreak in the United Kingdom during the 1980s/early 1990s, and have been in the past highly unlikely event (1% risk in any year) but if it should arise it would cause very high costs (e.g., £5 billion-similar in scale to BSE). The very high cost of such an event leads to the high "expected annual cost."
For the purpose of undertaking a cost-benefit analysis of the proposed new agency, the estimated set-up and annual running cost of the new agency were taken from Defra (2009b) (i.e., £14.3 million and £2.7 million, respectively). Therefore, the total cost, C, (£M) of set-up and running the new animal health agency and of outbreaks Table 1 . Potential occurrence and costs of minor and major outbreaks (Defra 2009b) . The y i and c i,major of "unknown major disease" were determined by Defra (2009b) based on their historical data of outbreaks that are, for example, similar in scale to the BSE outbreak in the United Kingdom during the 1980s/early 1990s, and have been in the past highly unlikely events (1% risk in any year) but if it should arise it would cause very high costs (e.g., £5 billion-similar in scale to BSE). The very high cost of such an event leads to the high "expected annual cost."
Probability that outbreak is in the 30-year period under consideration was determined in this article as:
These data were used in the following four scenarios (A-D) to estimate the total financial benefit of the new agency. The percentage cost reductions were arbitrarily determined and initially set out by Defra (2009b) . For Scenarios A-C in the scenario analysis, the costs of each outbreak were reduced accordingly. Within Scenario D, the number of (major and minor) outbreaks within each 10-year period was estimated and outbreak costs (with associated reductions 0.5%, 2%, 10%) applied to each period. The costs of outbreaks in the 30-year period were subsequently calculated by adding together the costs from the three periods considered, in addition to the set-up and running costs. In addition to the above scenario analysis, the impact of the new agency having an increased probability of an outbreak being minor (P i, minor ) was investigated for each disease on the total cost of the disease outbreaks (under the baseline scenario, i.e., without any additional financial benefits).
The Monte Carlo simulation model was executed using @Risk TM , with latin hypercube sampling, and run for 100,000 iterations. This number of iterations was sufficient to ensure convergence for the means of the number of minor and major outbreaks within a 95% confidence level (3% tolerance), which are the default settings in @Risk TM . Sensitivity analyses were undertaken using @Risk TM (Vose 2008) in order to ascertain the relative importance of all variables to the cost of animal disease outbreak for the baseline model.
RESULTS
Based on the simulated probabilities of a minor outbreak of disease i (P i,Minor ), the estimated number of minor outbreaks (O i,Minor ) over a 30-year period is shown in Figure 1 . This shows, for example, the number of minor outbreaks of ND was estimated to have a mean value of 9.5 (5th percentile 5; 95th percentile 15). Likewise, provided in Figure 2 is an estimate for the number of major outbreaks (O i,Major ) over 30 years based on the simulated probabilities of a major outbreak of disease i (P i,Major ). From Figure 1 , AI has a substantially higher number of minor outbreaks in a 30-year period (54 (42, 66)) compared to the other animal diseases. The 90th percentile range (2, 10) for major outbreaks of AI overlaps with other diseases, for example, BT, CSF, OKN (Figure 2) . Therefore the number of major AI outbreaks is more similar to the other animal diseases considered. The estimated costs (£M) due to minor and major animal disease outbreaks in 30 years (C i ) are shown in Figure 3 . Although it is predicted that the largest number of outbreaks will be from AI, it is the costs associated with an outbreak of an unknown major disease (UMD) that are the highest. In addition, the variability about the cost is wide with the 95th percentile at £5000 million. This is because, although the probability of having such an outbreak is low (1 in every 100 years), the cost of such an outbreak was estimated to the £5000 million. BT outbreaks would also be costly to the new organization, but the situation is slightly different here because the probability of an outbreak is high (once in every 2 years) and the cost is also relatively high. The costs of an AI outbreak are relatively low, and therefore although a high number of outbreaks may occur, overall, this disease would not contribute most to the cost of managing disease outbreaks. The other diseases have a much lesser impact on the estimated mean cost of outbreak management over a 30-year period. Based on the total mean cost per outbreak of the diseases and the likelihood that the disease outbreaks will occur over the 30-year period, total disease outbreaks (i.e., across all diseases) could potentially cost £4118 million (1925, 8440) . The large degree of variability associated with this overall estimate (as seen from the 5th and 95th percentiles) is attributable to the variability associated with an outbreak of a UMD, as discussed above.
From the scenario analysis (A-D) the costs of outbreak based on the estimated savings from setting up the new agency are compared in Figure 4 . This shows, for example, if the new agency achieved a reduction of 2% in the cost of animal disease outbreaks over 30 years (Scenario B), and with the expected cost of disease outbreaks over this time totalling £4118 million (1925, 8440) and the estimated set-up and annual running cost of the new agency (£14.3 million and £2.7 million, respectively), this would benefit £80 million. Likewise, if the new agency achieved a reduction of 0.5%, 2%, and 10% in the cost of animal disease outbreaks each year for years [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] respectively (Scenario D) , this would benefit £167 million after the set-up and annual running costs of the new agency are accounted for. Even at the minimal benefit of the new agency achieving a reduction of 0.5% in the cost of animal disease outbreak over 30 years (Scenario A), and with the set-up and annual running costs of the new agency, this would benefit £21 million.
An additional scenario analysis was carried out for the probability of an outbreak of disease i being minor (P i,Minor ) to see the effect of an improved outbreak response scenario over 30 years. A = 0.5% benefit, B = 2% benefit, C = 10% benefit, and D = 0.5%, 2%, and 10% benefit for years 1-10, 11-20, and 21-30, respectively. The dashed line denotes the estimated average total cost of animal disease outbreak without any financial benefits from setting up the new agency (i.e., £4118 million). (Color figure available online.)
initiative on the mean expected total cost of disease outbreaks without financial benefits from setting up the new agency ( Figure 5 ). For all of the diseases, except for UMD (for which by definition P i,Minor = 0), P i,Minor was increased from its baseline value given in Table 1 . From this analysis it is predicted that an improved outbreak response for AI and BT, in particular, could greatly reduce the costs of animal disease outbreak. The model is more sensitive to these two diseases because they are predicted to occur most frequently (i.e., two AI outbreaks per year and one BT outbreak every 2 years). A tornado chart for the sensitivity analysis is shown in Figure 6 . This shows that the total estimated cost of animal disease outbreaks over the 30 years was highly sensitive to the potential for an outbreak of a UMD. The other influential diseases were BT, FMD, and AI.
DISCUSSION
The use of a stochastic model enhances the RP method for dealing with the uncertainties regarding the proposed new agency for animal health in England. The RP approach assumes constant risk levels and factors over a decision period. When presenting the potential cost of future exotic disease outbreaks, Defra (2009b) acknowledge that the figures are not forecasts or predictions of what will, or is likely to, happen. Rather they illustrate the possible scale of outbreak costs and illustrate what might be achieved by reducing those costs. Animal disease spread changes in nature. Unknown animal diseases may emerge (e.g., Bovine Spongiform Encephalopathy), or new disease may appear through intrusion (e.g., African Horse Sickness) or environmental change (e.g., Bluetongue). While the stochastic model developed here incorporated RP, it also enabled observation of the probability of one or more outbreaks occurring within a specified time period. The stochastic approach therefore has a higher resolution than RP alone for assessing the impact of the new agency (Barbolini et al. 2003) . Compared to any deterministic approach, it provides additional information on the possible number of outbreaks and costs by providing 5th and 95th percentiles (Galson Sciences Limited 2001) . However, it is important Estimating Costs and Benefits for a New Animal Health Agency to note the inherent assumptions within this stochastic model. For example, over a 30-year period, the predicted frequency of the different outbreaks is likely to change dependent on the worldwide animal disease situation. Such changes would be potentially significant and it is therefore important that these data for the "chance of outbreak" are reviewed on a regular basis to assess if still realistic. Likewise the probability of a minor or major outbreak may change over time, dependent on outbreak control measures and livestock industry structures (e.g., animal movements). However, the scenario analysis carried out for P i,Minor indicates the total cost of the agency would only be significantly affected by changes in P i,Minor for AI and BT. It is estimated that the establishment of the new agency would be a viable investment. Even at the benefit rate of 0.5%, with the expected cost of disease outbreaks over the 30 years totalling £4118 million (1925, 8440) , and after the set-up and annual running costs are accounted for (£14.3 million and £2.7 million, respectively), the new agency would benefit £21 million (Figure 4) . Likewise, if the new agency could achieve a reduction of 2% in the cost of animal disease outbreaks over 30 years (Scenario B), there would be a benefit of £80 million. However, the potential benefits calculated based on the estimated costs of animal disease outbreaks were highly sensitive to the potential for an outbreak of a UMD. According to Defra's historical data (Defra 2009b) , an outbreak of a UMD has been in the past a highly unlikely event (1 in 100 years). Although if realized a UMD is estimated to cause very high costs that are similar in scale to the Bovine Spongiform Encephalopathy (BSE) outbreak in the United Kingdom during the 1980s/early 1990s (i.e., £5 billion).
Decision-making is complex and dynamic, particularly with regard to animal diseases. Qualitative factors such as technological (e.g., new vaccines), political (e.g., changing regulation on vaccination), and social considerations (e.g., cultures that may obstruct investment options) should also be considered (Khan 2008; Nowak 2005) . In addition, the most economically (quantitatively) viable decision may not necessarily be favored by governments. Our future work will be focusing on stochastic processes including non-homogenous Poisson processes, Cox processes, and mixed processes to model the occurrences of disease outbreaks. When costs associated with the occurrences of disease outbreaks are considered, marked Poisson processes models are suggested.
CONCLUSION
This article explored the applicability of a stochastic model to enhance the RP approach to animal disease risk assessment. The static nature of the RP approach limits its applicability for projecting the variability of the number of outbreaks over the lifespan of the proposed new agency for animal health in England. However, taking a stochastic approach this variability can be incorporated. The results from the stochastic model show that the average total cost of the new agency (including outbreak, set-up and running costs) is £4118 million with £1925 million and £8440 million as the 90% certainty interval. The large variability associated with the cost is attributable to the possibility of an UMD outbreak, although BT, FMD, and AI were also influential on the potential costs for the new agency. The results from the stochastic model also show that the new agency is likely to be a viable investment even with only a 0.5% reduction in disease costs, which could potentially save £21
